drugset
Drugs / Nasal Carbon Dioxide
last change Jun 2013 re-read 3 minutes ago

Nasal Carbon Dioxide

Developed for
migraine disorder · perennial allergic rhinitis
Investigated by
Capnia, Inc. · Madigan Army Medical Center · United States Naval Medical Center, Portsmouth · United States Naval Medical Center, San Diego · Walter Reed National Military Medical Center

Trials 2

today NCT01253915 · Ph 2 NCT00638755 · Ph 2
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01253915 Jan 2012 → Apr 2013 migraine disorder Capnia, Inc. Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT00638755 Feb → May 2008 perennial allergic rhinitis Capnia, Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Nasal Carbon Dioxide ClinicalTrials.gov intervention name — accepted as the source's own label NCT01253915 ↗
1

NCT00638755 ↗
Route Intranasal “Nasal Carbon Dioxide” NCT00638755 ↗